Norges Bank’s Global Cord Blood Corporation CO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-194,145
Closed -$602K 2191
2020
Q2
$602K Sell
194,145
-151,192
-44% -$439K ﹤0.01% 2043
2020
Q1
$1.1M Sell
345,337
-156,649
-31% -$685K ﹤0.01% 1974
2019
Q4
$2.51M Sell
501,986
-195,181
-28% -$932K ﹤0.01% 1965
2019
Q3
$3.37M Sell
697,167
-99,859
-13% -$524K ﹤0.01% 1952
2019
Q2
$4.61M Hold
797,026
﹤0.01% 1943
2019
Q1
$5.59M Buy
797,026
+152,671
+24% +$1.01M ﹤0.01% 1928
2018
Q4
$4.16M Hold
644,355
﹤0.01% 1944
2018
Q3
$4.5M Buy
644,355
+75,100
+13% +$564K ﹤0.01% 1978
2018
Q2
$5.4M Buy
569,255
+241,355
+74% +$2.31M ﹤0.01% 1935
2018
Q1
$3.35M Buy
+327,900
New +$3.35M ﹤0.01% 1949

Other funds holding CO

Norges Bank's CO Position: Q3 2020 in Review

Norges Bank sold out of Global Cord Blood Corporation (CO) in Q3 2020, closing a stake of 194,145 shares — an estimated $602K sold.

Norges Bank first reported a position in CO in Q1 2018 and held it in 10 quarters. The position peaked at $5.59M in Q1 2019. 28 funds tracked by Wall St. Rank hold CO as of Q3 2020.

  • Norges Bank reported no remaining Global Cord Blood Corporation position as of Q3 2020 after selling out during the quarter.
  • Norges Bank sold 194,145 Global Cord Blood Corporation shares in Q3 2020, an estimated $602K.
  • Norges Bank first reported a position in Global Cord Blood Corporation in Q1 2018 and held it in 10 quarters.
  • Norges Bank's Global Cord Blood Corporation position peaked at $5.59M in Q1 2019.
  • 28 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2020.

Based on Norges Bank's 13F filing for Q3 2020, filed 10 Nov 2020.